Cargando…

Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma

AIM: Atypical adenomatous hyperplasia (AAH) is a small glandular proliferation that has histological similarities with Gleason grade 1 and 2 prostatic adenocarcinoma (PACG1,2). There are no distinct histomorphological criteria distinguishing these two lesions from each other and other small glandula...

Descripción completa

Detalles Bibliográficos
Autores principales: Midi, Ahmet, Tecimer, Tülay, Bozkurt, Süheyla, Özkan, Naziye
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684265/
https://www.ncbi.nlm.nih.gov/pubmed/19468392
_version_ 1782167193178341376
author Midi, Ahmet
Tecimer, Tülay
Bozkurt, Süheyla
Özkan, Naziye
author_facet Midi, Ahmet
Tecimer, Tülay
Bozkurt, Süheyla
Özkan, Naziye
author_sort Midi, Ahmet
collection PubMed
description AIM: Atypical adenomatous hyperplasia (AAH) is a small glandular proliferation that has histological similarities with Gleason grade 1 and 2 prostatic adenocarcinoma (PACG1,2). There are no distinct histomorphological criteria distinguishing these two lesions from each other and other small glandular proliferations. Because treatment approaches are different for these lesions, it is necessary to determine histological criteria. The aim of this study is to review the histological features of these two lesions and to define new histological criteria distinguishing AAH from PACG1,2. We, therefore, assessed 18 anatomical and structural parameters. MATERIALS AND METHODS: We found 11 AAH (22 foci) and 15 PACG1,2 (22 foci) cases in 105 radical prostatectomy specimens. Basal cell-specific antikeratin was applied to these lesions. We assumed that PACG1,2 lesions did have not basal cells and we grouped the lesions as AAH and PACG1,2 based on this assumption. RESULTS: We found differences between AAH and PACG1,2 lesions for some parameters including the number of glands, structures such as the main ductus and basal cells. We found similar properties in the two lesions for the following parameters: localization, multiplicity, diameter of the lesion, focus asymmetry, distance between glands, inflammatory cells in and out of the lesions, secretory cell shape on the luminal side, papillary projection towards the luminal side of gland, the shape of the outer gland, the infiltrative pattern of the gland, glandular pleomorphism, biggest gland diameter and median gland diameter. CONCLUSION: We determined that concurrent evaluation of histomorphological features was important to differentiate between AAH and PACG1,2.
format Text
id pubmed-2684265
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-26842652009-05-22 Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma Midi, Ahmet Tecimer, Tülay Bozkurt, Süheyla Özkan, Naziye Indian J Urol Original Article AIM: Atypical adenomatous hyperplasia (AAH) is a small glandular proliferation that has histological similarities with Gleason grade 1 and 2 prostatic adenocarcinoma (PACG1,2). There are no distinct histomorphological criteria distinguishing these two lesions from each other and other small glandular proliferations. Because treatment approaches are different for these lesions, it is necessary to determine histological criteria. The aim of this study is to review the histological features of these two lesions and to define new histological criteria distinguishing AAH from PACG1,2. We, therefore, assessed 18 anatomical and structural parameters. MATERIALS AND METHODS: We found 11 AAH (22 foci) and 15 PACG1,2 (22 foci) cases in 105 radical prostatectomy specimens. Basal cell-specific antikeratin was applied to these lesions. We assumed that PACG1,2 lesions did have not basal cells and we grouped the lesions as AAH and PACG1,2 based on this assumption. RESULTS: We found differences between AAH and PACG1,2 lesions for some parameters including the number of glands, structures such as the main ductus and basal cells. We found similar properties in the two lesions for the following parameters: localization, multiplicity, diameter of the lesion, focus asymmetry, distance between glands, inflammatory cells in and out of the lesions, secretory cell shape on the luminal side, papillary projection towards the luminal side of gland, the shape of the outer gland, the infiltrative pattern of the gland, glandular pleomorphism, biggest gland diameter and median gland diameter. CONCLUSION: We determined that concurrent evaluation of histomorphological features was important to differentiate between AAH and PACG1,2. Medknow Publications 2008 /pmc/articles/PMC2684265/ /pubmed/19468392 Text en © Indian Journal of Urology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Midi, Ahmet
Tecimer, Tülay
Bozkurt, Süheyla
Özkan, Naziye
Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma
title Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma
title_full Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma
title_fullStr Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma
title_full_unstemmed Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma
title_short Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma
title_sort differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684265/
https://www.ncbi.nlm.nih.gov/pubmed/19468392
work_keys_str_mv AT midiahmet differencesinthestructuralfeaturesofatypicaladenomatoushyperplasiaandlowgradeprostaticadenocarcinoma
AT tecimertulay differencesinthestructuralfeaturesofatypicaladenomatoushyperplasiaandlowgradeprostaticadenocarcinoma
AT bozkurtsuheyla differencesinthestructuralfeaturesofatypicaladenomatoushyperplasiaandlowgradeprostaticadenocarcinoma
AT ozkannaziye differencesinthestructuralfeaturesofatypicaladenomatoushyperplasiaandlowgradeprostaticadenocarcinoma